Venus Remedies

67
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411B01019
  • NSEID: VENUSREM
  • BSEID: 526953
INR
1,624.50
-51.45 (-3.07%)
BSENSE

Oct 09

BSE+NSE Vol: 41.11 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
769.00
652.00
601.00
555.00
600.00
548.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
769.00
652.00
601.00
555.00
600.00
548.00
Expenditure (Ex Depriciation)
Stock Adjustments
-11.00
4.00
-2.00
8.00
3.00
-7.00
Raw Materials Consumed
398.00
373.00
357.00
322.00
383.00
347.00
Power & Fuel Cost
6.00
6.00
6.00
5.00
4.00
4.00
Employee Cost
88.00
80.00
71.00
61.00
56.00
46.00
Operating Expenses
22.00
17.00
12.00
8.00
8.00
6.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
74.00
60.00
61.00
48.00
45.00
63.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
1.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
622.00
584.00
541.00
495.00
538.00
494.00
Operating Profit (PBDIT) excl Other Income
147.00
68.00
59.00
60.00
62.00
53.00
Other Income
12.00
15.00
11.00
10.00
8.00
19.00
Operating Profit (PBDIT)
159.00
84.00
71.00
70.00
70.00
73.00
Interest
0.00
0.00
0.00
0.00
0.00
13.00
Profit before Depriciation and Tax
159.00
84.00
71.00
70.00
69.00
60.00
Depreciation
25.00
22.00
26.00
32.00
33.00
35.00
Profit Before Taxation & Exceptional Items
134.00
61.00
44.00
37.00
36.00
25.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
134.00
71.00
44.00
37.00
36.00
48.00
Provision for Tax
31.00
26.00
16.00
11.00
-4.00
-13.00
Profit After Tax
102.00
45.00
28.00
26.00
40.00
61.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
215.00
170.00
142.00
116.00
75.00
13.00
Profit Available for appropriations
318.00
215.00
170.00
142.00
115.00
75.00
Appropriations
318.00
215.00
170.00
142.00
115.00
75.00
Equity Dividend (%)
100.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
76.90
33.90
21.31
19.88
30.86
50.04
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 17.88% vs 8.55% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 114.89% vs 14.99% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -43.97% vs -30.10% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 126.83% vs 59.05% in Mar 2025

Compare Profit and Loss Results of Venus Remedies
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
769.00
489.00
280.00
57.26%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
769.00
489.00
280.00
57.26%
Expenditure (Ex Depriciation)
Stock Adjustments
-11.00
-3.00
-8.00
-266.67%
Raw Materials Consumed
398.00
288.00
110.00
38.19%
Power & Fuel Cost
6.00
5.00
1.00
20.00%
Employee Cost
88.00
67.00
21.00
31.34%
Operating Expenses
22.00
3.00
19.00
633.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
74.00
21.00
53.00
252.38%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
5.00
-4.00
-80.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
622.00
411.00
211.00
51.34%
Operating Profit (PBDIT) excl Other Income
147.00
77.00
70.00
90.91%
Other Income
12.00
31.00
-19.00
-61.29%
Operating Profit (PBDIT)
159.00
108.00
51.00
47.22%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
159.00
107.00
52.00
48.60%
Depreciation
25.00
6.00
19.00
316.67%
Profit Before Taxation & Exceptional Items
134.00
101.00
33.00
32.67%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
134.00
101.00
33.00
32.67%
Provision for Tax
31.00
24.00
7.00
29.17%
Profit After Tax
102.00
76.00
26.00
34.21%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
215.00
154.00
61.00
39.61%
Profit Available for appropriations
318.00
230.00
88.00
38.26%
Appropriations
318.00
230.00
88.00
38.26%
Equity Dividend (%)
100%
10%
90.00
Earnings Per Share
76.9
0.81
76.09
9,393.83%
Profit And Loss - Net Sales
Net Sales 769.60 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 17.88% vs 8.55% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 147.28 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 114.89% vs 14.99% in Mar 2025

Profit And Loss - Interest
Interest 0.04 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -43.97% vs -30.10% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 102.79 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 126.83% vs 59.05% in Mar 2025